Glaxosmithkline Pharmaceuticals Ltd. (GLAXO): Glaxosmithkline Pharmaceuticals Share Price rises 3.20% today to Rs 2,890
- September 18, 2026
- Posted by: Harsh Piplani
- Category: News
Glaxosmithkline Pharmaceuticals Share Price rose today as GLAXO moved to Rs 2,890, up 3.20% from the previous close of Rs 2,800.45. The company’s market capitalisation now stands at Rs 48,345.94 crore, placing the move in a large-value market context without any company-specific catalyst confirmed by the supplied data.
The stock opened at Rs 2,800.45, touched a day low of Rs 2,800.45 and a day high of Rs 2,890, and closed at the day’s high. Turnover stood at Rs 1.85 crore. For readers tracking Glaxosmithkline Pharmaceuticals Share Price Today, the verified data confirms a same-day rise, but it does not establish why the move happened. This GLAXO Stock News update therefore focuses on the price event, valuation backdrop, sector comparison and the key facts investors can monitor on Univest.
Glaxosmithkline Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,890 |
| Previous Close | Rs 2,800.45 |
| Today's Move | Rs 89.55 (+3.2%) |
| Open | Rs 2,800.45 |
| High | Rs 2,890 |
| Low | Rs 2,800.45 |
| Turnover | Rs 1.85 crore |
| Market Capitalisation | Rs 48,345.94 crore |
| Market Cap Category | Large Cap |
Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) rose to Rs 2,890 from the previous close of Rs 2,800.45, a move of Rs 89.55 or 3.2%. The stock opened at Rs 2,800.45, reached a high of Rs 2,890, recorded a low of Rs 2,800.45.
Glaxosmithkline Pharmaceuticals Share Price Today reflects a straight upward move from Rs 2,800.45 to Rs 2,890, a gain of Rs 89.55 or 3.20%. The stock traded between the same day’s low of Rs 2,800.45 and high of Rs 2,890, which means the session finished at the high point of the day. Turnover of Rs 1.85 crore provides a factual traded-value reference for the session. In simple terms, the data confirms a clear share price rise, but it does not establish a company-specific trigger. For GLAXO Stock News readers, the most relevant takeaway is that today’s move was cleanly positive and fully defined by the supplied price data.
Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 48,345.94 crore |
| P/E Ratio | 44.41x |
| P/B Ratio | 18.82x |
| ROE | 48.76% |
| ROCE | 66.79% |
| EPS | Rs 63.05 |
| Book Value Per Share | Rs 148.77 |
| Dividend Yield | 2.04% |
Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) fundamental metrics show P/E 44.41x, P/B 18.82x, ROE 48.76%, ROCE 66.79%. These figures provide context only and are not a buy or sell signal.
Glaxosmithkline Pharmaceuticals Ltd. has a market capitalisation of Rs 48345.94 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 44.41x, P/B at 18.82x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 48.76% and ROCE of 66.79%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 63.05, book value per share of Rs 148.77, dividend yield of 2.04%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.69x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 44.41x |
| Benchmark Median P/E | 32.69x |
| Benchmark Average P/E | 44.72x |
| Benchmark P/E Range | 3.44x to 417.17x |
| Company P/B Ratio | 18.82x |
| Benchmark Median P/B | 3.1x |
| Company ROE | 48.76% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 66.79% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 48,345.94 crore |
| Benchmark Median Market Cap | Rs 741.38 crore |
Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P/E ratio of 44.41x, which is above the benchmark median of 32.69x, a difference of +35.85%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROE of 48.76%, which is above the benchmark median of 11.78%, a difference of +313.92%. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROCE of 66.79%, which is above the benchmark median of 13.65%, a difference of +389.3%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 37.01 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,44,223.13 | 84.83 | 14.05 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,83,453.32 | 85.3 | 20.73 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,10,224.17 | 25.14 | 4.21 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,09,848.55 | 32.89 | 3.15 | 11.83 | 16 |
Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P/E ratio of 44.41x compared with the displayed peer median of 37.01x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 48.76% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 66.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a market capitalisation of Rs 48,345.94 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Glaxosmithkline Pharmaceuticals
- Glaxosmithkline Pharmaceuticals Share Price rose 3.20% today to Rs 2,890, and the session ended at the day’s high.
- The company’s market capitalisation is Rs 48,345.94 crore, which gives the move a large-capitalisation context in the Healthcare sector.
- P/E stands at 44.41 and P/B at 18.82, so GLAXO Share Price is trading on elevated valuation multiples.
- ROE of 48.76% and ROCE of 66.79% are both well above the same-industry benchmark medians.
- Turnover of Rs 1.85 crore and dividend yield of 2.04% add extra context to Glaxosmithkline Pharmaceuticals Share Price Today.
About Glaxosmithkline Pharmaceuticals
Glaxosmithkline Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s supplied business context is centred on its listed pharmaceutical identity rather than on a broader segment breakdown, so Glaxosmithkline Pharmaceuticals Share Price is best understood through its market position, profitability ratios and valuation metrics. The stock is listed on NSE and BSE under the symbol GLAXO, and its market capitalisation places it well above the median company size in the same industry dataset. For readers comparing GLAXO Stock News with broader sector coverage, the important point is that the company combines high ROE, high ROCE, EPS of Rs 63.05 and book value of Rs 148.77 with a premium P/B ratio. That mix makes it a closely followed name in Healthcare-oriented stock news and stock analysis coverage on Univest.
Track Glaxosmithkline Pharmaceuticals Share Price on Univest
Use Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track Glaxosmithkline Pharmaceuticals Share Price on Univest for live share price updates, company news, fundamental ratios, shareholding pattern, 52-week levels and market insights. The platform also helps users follow GLAXO Share Price Today alongside broader stock performance, peer comparison and sector context in one place. For those scanning Glaxosmithkline Pharmaceuticals Latest News or Glaxosmithkline Pharmaceuticals Share News, Univest keeps the data organised and easy to review without replacing factual market updates with commentary.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Glaxosmithkline Pharmaceuticals Share Price rise today?
Ans. The supplied data confirms a 3.20% rise to Rs 2,890, but it does not establish a company-specific catalyst. The session closed at the day’s high, which is the clearest verified price fact available.
What is Glaxosmithkline Pharmaceuticals Share Price today?
Ans. Glaxosmithkline Pharmaceuticals Share Price today is Rs 2,890. It rose Rs 89.55 from the previous close of Rs 2,800.45, giving the stock a 3.20% same-day gain in verified market data.
What is the market capitalisation of Glaxosmithkline Pharmaceuticals?
Ans. The company’s market capitalisation is Rs 48,345.94 crore. That places Glaxosmithkline Pharmaceuticals Share Price in a sizeable category within the Pharmaceuticals & Drugs industry, based on the supplied benchmark set.
How is Glaxosmithkline Pharmaceuticals valued versus peers?
Ans. GLAXO trades at a P/E of 44.41 and P/B of 18.82. Its P/E is below Divi’s and Torrent but above Sun Pharma, Cipla and Zydus, while its P/B is the highest in the supplied peer group.
What do ROE and ROCE show for Glaxosmithkline Pharmaceuticals Share Price?
Ans. ROE is 48.76% and ROCE is 66.79%. Both are above the same-industry benchmark medians, which is useful context when reviewing Glaxosmithkline Pharmaceuticals Share Price alongside its premium valuation ratios. The previous close was Rs 2,800.45.
Where can I track Glaxosmithkline Pharmaceuticals Share Price on Univest?
Ans. You can track Glaxosmithkline Pharmaceuticals Share Price on Univest for live price updates, fundamental ratios, shareholding pattern, company news and sector context. The platform brings GLAXO data together in one place for quick review.
